Nektar Therapeutics(NKTR)
SAN FRANCISCO, CABiotechnology
Focus: Nektar Therapeutics is a public biotechnology company focused on discovering and developing small molecules and biologics across oncology, immunology, and other therapeutic areas. The company operates as a mid-cap biotech with a diversified pipeline spanning 50+ active trials.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Nektar Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Nektar Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$98M
Key Products
Growth
Multi-indication immuno-oncology asset in Phase 1/2 and Phase 2 development across solid tumors.
Help build intelligence for Nektar Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.